OncoZenge AB's total assets for Q4 2025 were kr15.34M, a decrease of -22.69% from the previous quarter. DE:8LY total liabilities were kr15.92M for the fiscal quarter, a 51.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.